YASMIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Yasmin, and when can generic versions of Yasmin launch?
Yasmin is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in YASMIN is drospirenone; ethinyl estradiol. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Yasmin
A generic version of YASMIN was approved as drospirenone; ethinyl estradiol by DR REDDYS LABS SA on September 7th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for YASMIN?
- What are the global sales for YASMIN?
- What is Average Wholesale Price for YASMIN?
Summary for YASMIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Clinical Trials: | 36 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for YASMIN |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for YASMIN |
What excipients (inactive ingredients) are in YASMIN? | YASMIN excipients list |
DailyMed Link: | YASMIN at DailyMed |
Recent Clinical Trials for YASMIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Women's Hospital School Of Medicine Zhejiang University | Phase 4 |
Inonu University | N/A |
University of North Carolina, Chapel Hill | Phase 2 |
Paragraph IV (Patent) Challenges for YASMIN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
YASMIN | Tablets | drospirenone; ethinyl estradiol | 3 mg/0.03 mg | 021098 | 1 | 2005-01-07 |
US Patents and Regulatory Information for YASMIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | YASMIN | drospirenone; ethinyl estradiol | TABLET;ORAL-28 | 021098-001 | May 11, 2001 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for YASMIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Hlthcare | YASMIN | drospirenone; ethinyl estradiol | TABLET;ORAL-28 | 021098-001 | May 11, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Hlthcare | YASMIN | drospirenone; ethinyl estradiol | TABLET;ORAL-28 | 021098-001 | May 11, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Hlthcare | YASMIN | drospirenone; ethinyl estradiol | TABLET;ORAL-28 | 021098-001 | May 11, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for YASMIN
See the table below for patents covering YASMIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | PA02002043 | COMPOSICION FARMACEUTICA DE ETINILESTRADIOL Y DROSPIRENONA PARA EL USO COMO ANTICONCEPTIVO. (PHARMACEUTICAL COMBINATION OF ETHINYLESTRADIOL AND DROSPIRENONE FOR USE AS A CONTRACEPTIVE.) | ⤷ Sign Up |
Serbia | 20090134 | ⤷ Sign Up | |
Slovenia | 1214076 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for YASMIN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1380301 | 2009C/007 | Belgium | ⤷ Sign Up | PRODUCT NAME: DROSPIRENONE-ETHINYLESTRADIOL; AUTHORISATION NUMBER AND DATE: BE321386 20080811 |
0398460 | C00398460/01 | Switzerland | ⤷ Sign Up | FORMER OWNER: SCHERING AKTIENGESELLSCHAFT, DE |
0398460 | SPC/GB04/032 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: ESTRADIOL, OPTIONALLY IN THE FORM OF A HYDRATE, TOGETHER WITH DROSPIRENONE; REGISTERED: NL RVG 27505 20021211; UK PL 00053/0341 20040310 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |